Bayraktutan Dunhill Medical Trust EPC Study
Launched by UNIVERSITY OF NOTTINGHAM · Nov 29, 2016
Trial Information
Current as of May 30, 2025
Unknown status
Keywords
ClinConnect Summary
Ischaemic stroke develops through an interference with blood supply to the brain and continues to be one of the leading causes of morbidity and mortality in the World. Global medical statistics reveal that \~75% of all stroke patients are older than 65 years and that the stroke occurrence more than doubles every 10 years after the age of 55 in both men and women.
Although various mechanisms may alter the structure and function of the adult brain during the aging process, endothelial dysfunction is regarded as the main pathology that renders cerebral vessels susceptible to atherosclerosis a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Participants with Stroke:
- • Patients with anterior circulation IS and aged 65 years or older. Independence prior to stroke (mRS\<3). Ability to give informed consent (directly or via consultee).
- • Age Matched Controls (Healthy Volunteers) Individuals aged 65 years or above. No previous history of stroke. Ability to give consent to take part in the study.
- • Young Healthy Volunteers Individuals aged between 18 to 64 years of age. No previous history of stroke. Ability to give consent to take part in the study.
- Exclusion Criteria:
- * Participants with Stroke:
- • Patients with posterior circulation IS and aged below 65 years of age. Patients with recent recurrent IS. Patients with transient ischaemic attack or IS within the last 3 months. Patients with primary intracerebral haemorrhage.
- • Age Matched Controls (Healthy Volunteers) Individuals aged below 65 years of age. Previous history of stroke.
- * Young Healthy Volunteers (18-64):
- • Individuals aged below 18 years or are 65 years of age or above. Previous history of stroke.
About University Of Nottingham
The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nottingham, , United Kingdom
Nottingham, , United Kingdom
Patients applied
Trial Officials
Ulvi Bayraktutan, PhD
Principal Investigator
University of Nottingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials